C-TRI Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 222

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

  • Investments
  • 3

C-TRI General Information

Description

HLB Pharmaceutical Co Ltd is a research-oriented pharmaceutical company. It is engaged in developing medicines and drugs. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and other products.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
HLB Pharmaceutical
Former Stock Listing
047920
Corporate Office
  • 10th floor, Kowoon Institute of Technology Innovation
  • Suwon University, Gyeonggangro, Gyeonggi-do
  • Hwaseong, 445-743
  • South Korea
+82 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

C-TRI Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore C-TRI‘s full profile, request access.

Request a free trial

C-TRI Executive Team (2)

Name Title Board Seat Contact Info
WanJoo Kim Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

C-TRI Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

C-TRI Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore C-TRI‘s full profile, request access.

Request a free trial

C-TRI Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sears Pharmaceuticals (Rights to Rosu Duo) 24-Nov-2023 000000000 Other Pharmaceuticals and Biotechnology 000000 00
Verismo Therapeutics 27-Apr-2021 0000 00000 0000 Biotechnology
SuperTrans Medical 07-Apr-2020 Corporate 000 Pharmaceuticals
To view C-TRI’s complete investments history, request access »

C-TRI FAQs

  • When was C-TRI founded?

    C-TRI was founded in 1998.

  • Who is the founder of C-TRI?

    Wan-joo Kim is the founder of C-TRI.

  • Who is the CEO of C-TRI?

    WanJoo Kim is the CEO of C-TRI.

  • Where is C-TRI headquartered?

    C-TRI is headquartered in Hwaseong, South Korea.

  • What is the size of C-TRI?

    C-TRI has 222 total employees.

  • What industry is C-TRI in?

    C-TRI’s primary industry is Drug Discovery.

  • Is C-TRI a private or public company?

    C-TRI is a Private company.

  • What is C-TRI’s current revenue?

    The current revenue for C-TRI is 00000.

  • Who are C-TRI’s investors?

    Dae Hwa Pharm, Hyundai Venture Investment Corporation, and SL Investment have invested in C-TRI.

  • When was C-TRI acquired?

    C-TRI was acquired on 17-Oct-2019.

  • Who acquired C-TRI?

    C-TRI was acquired by HLB Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »